QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-90-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $90 p...

 viking-therapeutics-reports-q1-results-an-exceptional-period-says-ceo

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 ce...

 viking-therapeutics-q1-eps-026-beats-028-estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

 oppenheimer-maintains-outperform-on-viking-therapeutics-raises-price-target-to-138

Oppenheimer analyst Jay Olson maintains Viking Therapeutics (NASDAQ:VKTX) with a Outperform and raises the price target from...

 oppenheimer-maintains-outperform-on-viking-therapeutics-raises-price-target-to-138

Oppenheimer analyst Jay Olson maintains Viking Therapeutics (NASDAQ:VKTX) with a Outperform and raises the price target from...

 stocks-inch-higher-tesla-rebounds-bitcoin-holds-below-70000-whats-driving-markets-tuesday

Wall Street is set to break a two-day losing streak on Tuesday, as major indices trended positively during midday trading in Ne...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION